Compliance Review for Eye Care Copy: A Practical Checklist

The copy review on an eye care project usually happens in the wrong order. The sample is approved, the artwork is laid out, the launch date is booked, & only then does somebody read the carton the way a reviewer reads it. By that point a single line on the front panel can force a reprint, restart a notification or get a listing suppressed, & the cost of that line is no longer confined to the print bill.

This is a working checklist for the wording on eye creams, eye serums, under-eye patches & eye gels. It sorts the sentences that are safe, the sentences that are borderline & the sentences that cannot be defended, then shows how one product is read differently by the brand owner, the factory's regulatory desk, a marketplace sweep & a customs officer. The aim is to settle the copy while the formula is still on the bench.

Why eye area copy is read more closely than face copy

The eye area is thin, mobile & close to a mucous membrane, so a product positioned for that zone is read with more caution than a product positioned for the cheek. The legal category is the same cosmetic category, but the distance between an ambitious line of copy & a complaint is much shorter, which is why reviewers slow down on this shelf.

The consequence is that phrasing which raises no question on a body lotion will raise one here. Language about the eye itself, the lid margin, the lash line or the surface of the eye invites a different reading from language about the skin around it. A brand can describe the surrounding skin freely; the moment the sentence moves inward, the scrutiny changes.

There is a commercial reason as well. Eye products are usually sold in small volumes at a high unit price, so the front panel carries more of the selling job & gets written more aggressively. That pressure is exactly what produces the risky sentence, & it is why this category needs the review earlier than the others rather than later.

Sort every sentence before you rewrite any of it

The first pass is not editing, it is sorting. Collect every sentence that will be published, meaning the carton, the tube, the leaflet, the listing title, the bullets, the video overlay & the reply templates, then place each one in one of three piles: describes, suggests, promises.

A sentence describes when it states what the product is, what it contains, how it is used, how much is in the pack or what it feels like during application. A sentence suggests when it uses sensory or appearance language tied to normal use. A sentence promises when it states a change to a condition, a cause, or an outcome the user could measure.

The eye category usually fails in the middle pile, because everyday sensory words drift when the subject is the eye. A phrase that only means the product feels cool on application reads as a condition statement once the same words sit under an eye product, & the drift happens without anyone editing the sentence.

Where a cosmetic line stops & a medicine line starts

A cosmetic may describe appearance, normal function & the sensory behaviour of the product. It may not promise to change a physiological condition or explain the cause behind what the user sees. A line that says a shadow or a bag will go away, or that names a mechanism such as fluid retention, is the kind of line that fails this test.

Comparisons to a procedure fail in the same way. Wording that implies a clinic result, a needle or an effect of the kind a salon room delivers pushes the product towards a different classification in most markets, & the push comes from the comparison rather than from anything in the ingredient list.

What can be said is narrower but still workable. The product may state its format, its ingredient content at a declared level, its intended use, its texture, its finish & how it should be applied. It may describe the look of the area while the product is on the skin, & it may state the basis of any study it holds in neutral terms.

One subtlety is that the same sentence can be safe on a face product & unsafe on an eye product, because the reader assumes a stronger effect on the eye. Audience expectation is part of how a claim is assessed, so the review has to be done for the shelf the product will be sold from rather than for the words in isolation.

Ingredient names, INCI order & the panel that is not marketing

INCI names belong on the ingredient list, in descending order of concentration down to the threshold the market sets, then in any order below it. The ingredient list is a declaration, not a marketing panel, & merging the two is the mistake that produces a carton which fails at review even though nothing printed on it is false.

Eye formulas often carry a short ingredient list & a mild preservation system, which makes the panel easier for a shopper to read & therefore more commercially sensitive. That is a reason to keep the list accurate, not a reason to reorder it or to shorten it by dropping a component that is present above the threshold.

Naming an ingredient on the front panel is normally allowed as description, but a name plus an outcome becomes a combined claim. A single word naming an ingredient is one thing; the same word joined to a statement about what the skin will do is the sentence a reviewer will test, & the test is applied to the pair rather than to the name alone.

Trade names need one more check. A trademarked complex used in marketing copy has to be licensed for that use, & a trade name does not become part of the INCI declaration. Brands that print a supplier's trade name on the front panel without written permission tend to discover the problem at the printer rather than at the desk.

Fragrance, the IFRA 26 allergens & the flash point question

Fragrance is where an eye product collects paperwork. The IFRA standards set use limits by product category, the 26 allergens that must be declared have to be identified & quantified against the applicable threshold, & the fragrance house has to issue both the certificate & the allergen declaration before the label can be finalised.

There is also a category-specific reason to think twice. The eye area is usually where a sensory reaction shows first, so a scented eye product is more likely to come back with a stinging complaint than the same scent in a body lotion. Many brands keep the eye product free of fragrance & put the signature scent on the face cream, & that split is worth deciding at the brief stage.

Alcohol & volatile fragrance components bring transport into the conversation. A low flash point means the goods are classified as a flammable liquid for shipping, which changes the packing requirements, the air freight documentation & which carriers will accept the consignment. Ask for the flash point & the safety data sheet before the freight quote is built, because a reclassification after booking is an expensive correction.

Where an allergen sits above the threshold, the market usually requires the name on the label, often in a short "contains" line. That line is part of the artwork, so it has to be known before the dieline is signed off rather than added on a sticker in the warehouse.

Preservative declarations & the trap inside "free from"

An eye formula is usually water-rich & packed in a small volume, so preservation is a design requirement rather than a preference. The copy question is what can be said about the system. A tested preservation system can be described in neutral terms, but describing the product as though it removes or blocks micro-organisms is a disinfectant claim & belongs to a different category of product altogether.

Preservative-free wording is a specific trap. The line is only defensible where there is genuinely no preservative in the formula, & a multifunctional ingredient that is doing the same job is a grey area many reviewers will challenge. If the formula leans on such an ingredient, the honest position is to describe the system rather than to make the negative claim.

pH is the other half of the same conversation. Several preservation systems work only inside a narrow window, so a copy line that promises a particular pH together with an effect on the skin joins two statements that are assessed separately. Keep pH in the specification & keep the front panel out of it.

What you may say about the testing you actually hold

Testing language is where careful brands still trip, because a completed study supports a statement about the study rather than a statement about what will happen to a user. The distinction sounds academic until an automated marketplace sweep reads a test reference as a promise to the buyer.

Some markets expect an ocular tolerance assessment for products used around the eye. The fact that an assessment was carried out can be communicated to a buyer or a retailer in neutral terms, but it does not license wording about every user, every eye or every skin type, & it never turns into an absolute statement about the absence of a reaction.

Consumer panels work differently. A study in which participants recorded their own opinion can support wording that reports those opinions, provided the basis is documented & the wording stays inside what was actually asked. It cannot support wording about a biological change, because the panel did not measure one.

Imagery, before & after layouts & influencer wording

In many markets imagery is assessed as advertising copy, so a diagram drawn over a line, an arrow on a lifted brow or a split image lit differently on each side is read as a claim rather than as decoration. The safest imagery shows the product, its texture & a normal use occasion without implying a comparison over time.

Under-eye patches are the format where this bites hardest, because the product photographs well on a face. The photograph itself is usually fine; the caption, the video overlay & the thumbnail text are where the promise gets added, & those three are frequently written by somebody who has never seen the copy rules.

Reviews & user content need a rule of their own. Where a brand reposts a customer comment that promises an outcome, several markets regard the brand as having adopted the statement. A one-page internal rule about what may be reposted, & a habit of quoting texture & experience rather than outcomes, is cheaper than a takedown request.

Marketplace listing copy is reviewed twice over

The carton is reviewed against cosmetic rules. A listing is reviewed against platform policy on top of consumer law, & the platform usually applies automated keyword checks that are stricter than either. A listing can therefore be suppressed for wording that would pass a regulatory review without comment.

The hidden fields are the ones brands forget. Search terms, backend keywords, the alt text of an image, text burned into a video & even a bullet symbol used as a graphic can all be read by a sweep. A word list that is blocked on the channel should be kept separately from the list that is blocked by regulation.

The workable arrangement is one master copy sheet with a channel column beside it. The brand owns the sheet, the factory supplies the technical facts that fill it, & neither side rewrites the other's part. That single file removes most of the arguments that otherwise happen after a listing goes down.

One formula, several markets, & the drift in translation

A single formula can need several copy reviews, because the markets do not share one rule set. A notification in one region, a responsible person arrangement in another, a label language requirement in a third & a different tolerance for claim language mean the same carton cannot be assumed to travel unchanged.

Translation is where the drift happens. A word chosen to keep a line short can land with a stronger meaning in the target language, & a literal back translation is the cheapest way to catch it. Print the back translation beside the original & have somebody who did not write the original read both versions.

The practical tool is a copy matrix with one row per line & one column per market. Each cell holds either the approved wording or a note explaining why the line does not travel, & the matrix becomes the document that a distributor, a marketplace appeal & a customs question are all answered from.

Copy line types compared

The table below sets out the kinds of line that appear on eye care copy, what each one does commercially, the direction that keeps it defensible & the risk that follows when the line is written more strongly than the file behind it supports.

The rows are a working map rather than a rule book. Two markets can read the same line differently, & a channel can be stricter than the law it sits under, so the row that applies to your product has to be confirmed for each destination before the artwork is signed off rather than after the plates are made.

What to put in the brief

Write the brief so the copy review is a scheduled step rather than a rescue. State the launch market first, because that line sets the language, the notification route & the tolerance for claim language. Then list every sentence you intend to publish, including the listing, the leaflet & the reply templates, so the factory can see the whole set instead of only the carton.

• The markets where the product will be sold, & the one it launches in first.
• The front panel wording, including any ingredient name used as a selling point.
• Any study, panel or assessment you intend to refer to, & where the report sits.
• Whether fragrance is included, & who issues the IFRA certificate & allergen declaration.
• Whether the pack carries a "free from" line, & which items it covers.
• The channels the copy will run on, & any channel word list that is stricter than the law.
• Who owns the master copy sheet, & who signs off the back translation per market.
• The artwork deadline, so the review sits before layout rather than after it.

Then agree what happens when a line cannot be supported. The useful arrangement is that the factory flags the sentence & proposes a replacement in the same reply, so the brand is choosing between two usable lines rather than negotiating a deletion. Copy reviewed this way rarely delays a launch, while copy reviewed at the printer nearly always does.

Where our capability fits

We review eye care copy against the formula & the file rather than against the design. That means the ingredient list, the declared content levels, the preservation basis & the position on fragrance are all checked in the same pass as the front panel, & any line that cannot be supported is flagged with a replacement in the same reply. On eye-area projects we work with short ingredient lists & mild preservation, & we document what each statement on the pack rests on.

We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing & full custom formula development, & the paperwork is assembled alongside the sample rather than after it. Adjacent lines produced under the same discipline include a soothing repair face cream, a copper peptide repair serum & a ceramide essence capsule range.

Tell us the markets, the channels & the sentences you want to publish, & we will come back with which lines hold, which need rewording & what the file has to contain. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319. For the formulation background behind eye-area products, see our eye cream formulation guide & how claim wording travels between markets.

General manufacturing information, not regulatory or legal advice. Claim wording rules, allergen labelling thresholds, declaration duties & transport classification vary by market & by product, & the applicable requirements should be confirmed for each destination before a product is placed on sale.